Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,942
  • Shares Outstanding, K 32,057
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,570 K
  • EBIT $ -54 M
  • EBITDA $ -53 M
  • 60-Month Beta 2.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 256.78% (-218.62%)
  • Historical Volatility 85.37%
  • IV Percentile 41%
  • IV Rank 22.41%
  • IV High 806.91% on 12/05/25
  • IV Low 97.86% on 04/04/25
  • Expected Move (DTE 6) 1.0625 (97.48%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 8,450
  • Open Int (30-Day) 9,013
  • Expected Range 0.0275 to 2.1525

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.36
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0900 unch
on 12/12/25
1.5200 -28.29%
on 11/13/25
-0.4300 (-28.29%)
since 11/12/25
3-Month
1.0900 unch
on 12/12/25
4.9902 -78.16%
on 10/03/25
-3.1600 (-74.35%)
since 09/12/25
52-Week
1.0900 unch
on 12/12/25
5.7500 -81.04%
on 06/27/25
-2.2600 (-67.46%)
since 12/12/24

Most Recent Stories

More News
SKYE DEADLINE: Faruqi & Faruqi Reminds Skye Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options

SKYE : 1.0900 (-5.22%)
Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SKYE

NEW YORK , Dec. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities...

SKYE : 1.0900 (-5.22%)
Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE).

SKYE : 1.0900 (-5.22%)
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Dec. 11, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience,...

SKYE : 1.0900 (-5.22%)
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE

LOS ANGELES , Dec. 11, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Skye Bioscience, Inc. ("Skye " or "the Company") (NASDAQ: SKYE ) for violations...

SKYE : 1.0900 (-5.22%)
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

NEW YORK , Dec. 10, 2025 /PRNewswire/ --

SKYE : 1.0900 (-5.22%)
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing

PHILADELPHIA , Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ:...

SKYE : 1.0900 (-5.22%)
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK , Dec. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities...

SKYE : 1.0900 (-5.22%)
Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

NEW YORK , Dec. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Skye Bioscience, Inc. (NASDAQ: SKYE).

SKYE : 1.0900 (-5.22%)
Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation

SAN DIEGO , Dec. 8, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of Skye Bioscience, Inc. (NASDAQ:...

SKYE : 1.0900 (-5.22%)

Business Summary

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

See More

Key Turning Points

3rd Resistance Point 1.2400
2nd Resistance Point 1.2100
1st Resistance Point 1.1500
Last Price 1.0900
1st Support Level 1.0600
2nd Support Level 1.0300
3rd Support Level 0.9700

See More

52-Week High 5.7500
Fibonacci 61.8% 3.9699
Fibonacci 50% 3.4200
Fibonacci 38.2% 2.8701
Last Price 1.0900
52-Week Low 1.0900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar